Antibody therapies for lymphoma in children - Wikidata - awgldk - TriplyDB

Antibody therapies for lymphoma in children

Antibody therapies for lymphoma in children

http://www.wikidata.org/entity/Q24186437

about

Mortality and survival patterns of childhood lymphomas: geographic and age-specific patterns in Southern-Eastern European and SEER/US registration data.

P2860

Q31131542-CCBA6576-4DF2-4728-B3C0-D82EF850915D

P2860

Antibody therapies for lymphoma in children

http://www.wikidata.org/entity/Q24186437

description

2016 nî lūn-bûn

@nan

2016 թուականի Յունուարին հրատարակուած գիտական յօդուած

@hyw

2016 թվականի հունվարին հրատարակված գիտական հոդված

@hy

2016年の論文

@ja

2016年論文

@yue

2016年論文

@zh-hant

2016年論文

@zh-hk

2016年論文

@zh-mo

2016年論文

@zh-tw

2016年论文

@wuu

name

Antibody therapies for lymphoma in children

@ast

Antibody therapies for lymphoma in children

@en

Antibody therapies for lymphoma in children

@nl

type

label

Antibody therapies for lymphoma in children

@ast

Antibody therapies for lymphoma in children

@en

Antibody therapies for lymphoma in children

@nl

prefLabel

Antibody therapies for lymphoma in children

@ast

Antibody therapies for lymphoma in children

@en

Antibody therapies for lymphoma in children

@nl

P1433

Q24186437-62E8E281-9B04-45E9-AAB5-82C45C7937CF

P1476

Q24186437-3F6656B2-B37F-4598-81E2-F21668DBD3EE

P2093

Q24186437-57DA43CB-F4DD-4711-804A-1BB6C0042202

Q24186437-D0E17B97-E555-4A49-B74D-69D248564EB5

Q24186437-DD4945E4-F7FA-4D93-B7A9-AF4E6878DFAB

P2860

Q24186437-00732CA7-995F-4F86-88BF-3301B1E0CEFA

Q24186437-00D3BFF4-3526-4879-B2A7-CF95E36B31EA

Q24186437-1906D021-23E6-41AB-830E-DC40B28D21CB

Q24186437-2680E2D6-015A-44ED-AF88-868CA388459C

Q24186437-27882330-846D-43DF-B9F8-02FD5534AC5B

Q24186437-46AF936B-AF31-40C1-8003-979670EB7CE8

Q24186437-48BCB5A1-FA5D-4178-92AD-B60D7E6143CB

Q24186437-5A789B8D-0A68-41A9-A837-CCFC3B46531B

Q24186437-5FC1809D-7AA4-46A9-839D-15A5B37FD6D8

Q24186437-62CD2FDA-B4DF-4D12-9FF5-FE1C87353333

P31

Q24186437-35C6237B-F3F8-4004-80BF-2B167E19B587

P356

Q24186437-E46719E3-73CA-450D-9F78-5ED0534D25D4

P577

Q24186437-42155582-2D43-493D-8243-6153708AD52C

P698

Q24186437-03283A3F-A3C6-41AC-BA2C-0BBD4F99863D

P356

14651858.CD011181.PUB2

P1433

Cochrane Database of Systematic Reviews

P1476

Antibody therapies for lymphoma in children

@en

P2093

Friederike AG Meyer-Wentrup

http://www.w3.org/2001/XMLSchema#string

Samantha C Gouw

http://www.w3.org/2001/XMLSchema#string

Verena de Zwart

http://www.w3.org/2001/XMLSchema#string

P2860

Antibody therapies for lymphoma in children

Chemotherapy plus Rituximab versus chemotherapy alone for B-cell non-Hodgkin's lymphoma

Antibody therapy of cancer

Immune-based therapeutics for pediatric cancer.

Immunotherapy for pediatric cancer.

Monoclonal antibodies: versatile platforms for cancer immunotherapy.

Rituximab with chemotherapy in children and adolescents with central nervous system and/or bone marrow-positive Burkitt lymphoma/leukaemia: a Children's Oncology Group Report.

Molecular distinctions between pediatric and adult mature B-cell non-Hodgkin lymphomas identified through genomic profiling

Rituximab and FAB/LMB 96 chemotherapy in children with Stage III/IV B-cell non-Hodgkin lymphoma: a Children's Oncology Group report.

Childhood and adolescent non-Hodgkin lymphoma: new insights in biology and critical challenges for the future.

P31

scholarly article

P356

10.1002/14651858.CD011181.PUB2

http://www.w3.org/2001/XMLSchema#string

P577

2016-01-19T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

26784573

http://www.w3.org/2001/XMLSchema#string